Newsroom | 2348 results

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announced today the participation in two upcoming investor conferences. Information on the conferences can be found below. TD Cowen 10th Annual Future of the Consumer Conference William Blair 46th Annual Growth Stock Conference TD Cowen Future of the Consumer Conference Owlet will participate in the TD Cowen 10th Annual Future of the Consumer Conference, taking place on June...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on May 15, 2026, an inducement grant (the “Inducement Grant”) was made to Anthony Catalano in connection with the commencement of his employment as the Chief Operating Officer of the Company. The Inducement Grant consists of restricted stock units (“RSUs”) covering 141...

LYON, France--(BUSINESS WIRE)--MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2026...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented new positive clinical data for plozasiran supporting its use in patients with moderate-to-severe renal impairment or moderate hepatic impairment without the need for dose adjustment, and a case report suggesting that preconception exposure to plozasiran may be associated with sustained lowering of fasting triglyceride (TG) levels through the term of a pregnancy. The data were presented in two oral...

CHICAGO--(BUSINESS WIRE)--Today, Artisight announced that The MetroHealth System, Northeast Ohio’s largest safety net health system, has selected the Artisight Smart Hospital Platform for deployment across nearly 500 patient rooms spanning five facilities in the Cleveland area. The deployment will bring Virtual Nursing, Virtual Sitting, and integrated AI services to MetroHealth’s clinical teams, starting at The Glick Center, the state-of-the-art hospital that opened in late 2022 on the health s...

SAN DIEGO--(BUSINESS WIRE)--Iambic is a CNBC Disruptor 50 for the second year in a row, joining the ranks of repeat Disruptors OpenAI, AirBnB, and SpaceX. The Disruptor 50 is an annual list curated by CNBC to recognize the most innovative and fast-growing private companies reshaping the economy. Nominees go through a rigorous vetting process based on scalability, customer growth, and use of breakthrough technology. “Iambic is proving that better technology leads to better medicines, and this re...

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, has been named to the 2026 CNBC Disruptor 50 list of the world’s most innovative private companies. The annual list recognizes category-defining businesses whose breakthrough technologies are transforming industries and shaping the future. This honor reflects a landmark year for WHOOP. In May 2025, the company launched the WHOOP 5.0 and WHOOP MG, next-generation wearables designed to deliver highly personalized insights across healt...

SAN DIEGO & EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new system will be available in Germany soon. Dexcom Flex is made for people using basal insulin, oral medications or GLP-1 receptor agonists, expanding access to CGM technology for a broader Type 2 diabetes population. D...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Token, the next-generation biometric identity assurance company, named Daniel K. Van Ostrand its Head of Engineering and Product. The appointment comes at a defining moment for enterprise security. Credential compromise remains the leading cause of enterprise breaches, and AI has made the problem structurally worse—phishing, deepfakes, and social engineering now operate at machine speed and scale, while the credentials underneath have not fundamentally changed...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that insights from the LifeVest® wearable cardioverter defibrillator (WCD) helped physicians achieve better heart rate control in female patients – an indicator of more rapid beta-blocker optimization and an outcome associated with improved survival. These findings come from the Optimizing Beta‑Blocker Dosage in Female Patients Using the Wearable Cardiove...